Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
Yapanis M, James S, Craig ME, O'Neal D, Ekinci EI.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2221-e2236. doi: 10.1210/clinem/dgac034.
PMID:35094087
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
De Meulemeester J, Charleer S, Visser MM, De Block C, Mathieu C, Gillard P.
Diabetologia. 2024 Aug;67(8):1527-1535. doi: 10.1007/s00125-024-06171-y. Epub 2024 May 24.
PMID:38787436
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R.
Lancet. 2016 Nov 5;388(10057):2254-2263. doi: 10.1016/S0140-6736(16)31535-5. Epub 2016 Sep 12.
PMID:27634581
Blood immune cell profiling in adults with longstanding type 1 diabetes is associated with macrovascular complications.
He X, Wang X, van Heck J, van Cranenbroek B, van Rijssen E, Stienstra R, Netea MG, Joosten I, Tack CJ, Koenen HJPM.
Front Immunol. 2024 Jul 1;15:1401542. doi: 10.3389/fimmu.2024.1401542. eCollection 2024.
PMID:39011037
Global and societal implications of the diabetes epidemic.
Zimmet P, Alberti KG, Shaw J.
Nature. 2001 Dec 13;414(6865):782-7. doi: 10.1038/414782a.